Test Price
2,800 AED✅ Home Collection Available
TWIST1 Gene Craniosynostosis Type 1 Genetic Test in UAE | 2800 AED | Clinical Genetics NGS Analysis
Executive Summary & Core Metrics
▪ 99.9% Diagnostic Sensitivity – ISO 9001:2015 certified processing ensures clinical-grade accuracy for TWIST1 mutation detection across the full coding region.
▪ Premium Logistics – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
▪ Clinical Guidance – Complimentary telephonic post-test interpretation with a Consultant Medical Geneticist.
▪ Insurance & Billing – Direct verification via WhatsApp +971 54 548 8731. We handle prior approvals for all major UAE networks.
Test Overview & Methodology
The TWIST1 Gene Craniosynostosis Type 1 NGS Test analyses the entire coding region of TWIST1 by next-generation sequencing to confirm or rule out pathogenic variants linked to Saethre-Chotzen syndrome and isolated craniosynostosis. This molecular diagnostic assay is essential for paediatric differential diagnosis, surgical planning, and family genetic counselling under the UAE's clinical genetics framework.
| Feature | Our Test (DHA Approved) | Closest Alternative |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene analysis | Sanger sequencing (limited to known hotspots) |
| Turnaround Time | 3–4 weeks (expedited available) | 6–8 weeks |
| Clinical Reporting | DHA-compliant, includes ACMG variant interpretation | Often basic report without clinical correlation |
| Home Collection | Yes – VIP Mobile Phlebotomy with temperature-controlled cold-chain (8 AM – 11 PM) | Clinic visit only |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I recognise the profound anxiety families face when craniosynostosis is suspected. The TWIST1 NGS test provides definitive molecular confirmation, but it is not a substitute for a comprehensive clinical evaluation and cranial imaging. Results must always be interpreted in the context of the patient's full dysmorphology and family history. Correlation with prenatal or neonatal ultrasound findings is strongly advised before surgical intervention."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medical Advisory
Do not discontinue any prescribed medication or alter your child's surgical plan based solely on this test result. Always discuss all laboratory findings with your treating physician or neurosurgeon. Genetic test outcomes are probabilistic, not deterministic, and require expert clinical correlation. If the child exhibits signs of raised intracranial pressure (projectile vomiting, severe irritability, downward gaze "sun-setting" sign), seek immediate neurosurgical care — do not delay for genetic results.
Patient Exclusion Criteria & Safety Guidelines
- Sample Rejection: Hemolysed or clotted blood, insufficient DNA (<1 μg), or FTA card with contamination.
- Paediatric Consent: Under Federal Decree-Law No. 4 of 2016 on Medical Liability and the UAE Personal Data Protection Law, testing on minors requires documented informed consent from the legal guardian and a pre-test counselling session.
- Result Limitation: A negative NGS result does not rule out other craniosynostosis genes or non-genetic suture fusion.
Patient FAQ & Clinical Guidance
1. How accurate is the TWIST1 NGS test for diagnosing craniosynostosis type 1 in my child?
The test achieves 99.9% analytical sensitivity and specificity for single-nucleotide variants and small indels within the TWIST1 gene, using ISO 9001:2015 accredited protocols and ACMG variant classification standards, ensuring that a pathogenic variant will be detected if present.
2. What sample is required and how is it collected at home?
A simple blood draw (1–2 mL in EDTA tube), one drop of blood on an FTA card, or previously extracted DNA can be used. Our VIP Mobile Phlebotomist arrives with a temperature-controlled cold-chain transport box between 8 AM and 11 PM to guarantee specimen integrity for sequencing.
3. Will my health insurance cover this genetic test in the UAE?
Most UAE insurers cover medically necessary genetic testing for craniosynostosis when pre-authorized. Our team verifies your policy and obtains approval via direct billing — simply send your Emirates ID and insurance card to WhatsApp +971 54 548 8731 for immediate verification.
4. How long does it take to receive results, and how are they delivered?
The standard turnaround time is 3–4 weeks from sample receipt. An expedited option is available for urgent clinical cases. Results are delivered electronically via secure DHA-compliant digital report and include a telephonic consultation with our Consultant Medical Geneticist for interpretation.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with the UAE's healthcare data protection and medical liability frameworks. All genetic data generated from this test is handled under:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records and telemedicine consultations.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring clinical safety, informed consent, and patient rights throughout the diagnostic pathway.
- Dubai Health Authority (DHA) standards – Facility License No. 1143, with regular audits and ISO 9001:2015 quality management certification.
Patient data is encrypted at rest and in transit, access is role-based and audited, and genetic results are retained only as long as required by UAE federal law. No data is shared with third parties without explicit written consent.
Clinical & Logistical Metadata
| Test Name | TWIST1 Gene Craniosynostosis Type 1 NGS Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks (expedited available) |
| Sample Type / Matrix | Whole blood (EDTA), FTA card, or extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding region analysis |
| ICD-10-CM Code | Q75.0 (Craniosynostosis), Q87.0 (Congenital malformation syndromes predominantly affecting facial appearance) |
| LOINC Code | 101261-4 (TWIST1 gene mutation analysis in Blood by NGS) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians